{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:38:40Z","timestamp":1781879920390,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cpcardiol.2023.101857","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T06:18:07Z","timestamp":1686205087000},"page":"101857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Great Sustainability Results From Appropriate Antihypertensive Therapy"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-6783","authenticated-orcid":false,"given":"Francesco","family":"Ferrara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Langella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2023.101857_bib0001","unstructured":"Comorbidity in the Italian population: Istituto Superiore di Sanit\u00e0 (2015). Available at: https:\/\/www.iss.it\/rapporti-istisan. Accessed February 2023"},{"key":"10.1016\/j.cpcardiol.2023.101857_bib0002","unstructured":"National chronicity plan 2016. Available at: https:\/\/www.salute.gov.it\/portale\/esenzioni\/dettaglioPubblicazioniEsenzioni.jsp?id=2584. Accessed February 2023"},{"key":"10.1016\/j.cpcardiol.2023.101857_bib0003","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejpain.2011.07.006","article-title":"Socio economic burden of patients with a diagnosis related to chronic pain: register data of 840,000 Swedish patients","volume":"16","author":"Gustavsson","year":"2011","journal-title":"Eur J Pain"},{"key":"10.1016\/j.cpcardiol.2023.101857_bib0004","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/258535","article-title":"The valuation of human capital","volume":"69","author":"Weisbrod","year":"1961","journal-title":"Polit Econ"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101857_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00129784-200202020-00002","article-title":"Antihypertensive drugs: an overview","volume":"2","author":"Ram","year":"2002","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2A","key":"10.1016\/j.cpcardiol.2023.101857_bib0006","doi-asserted-by":"crossref","first-page":"25K","DOI":"10.1016\/S0002-9149(99)00363-X","article-title":"Pharmacoeconomic issues in antihypertensive therapy","volume":"84","author":"Giles","year":"1999","journal-title":"Am J Cardiol"},{"issue":"33","key":"10.1016\/j.cpcardiol.2023.101857_bib0007","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"7-8","key":"10.1016\/j.cpcardiol.2023.101857_bib0008","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00508-018-1435-8","article-title":"What's new in the ESC 2018 guidelines for arterial hypertension: the ten most important messages","volume":"131","author":"Bergler-Klein","year":"2019","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.cpcardiol.2023.101857_bib0009","unstructured":"European Society of Cardiology. ESC Clinical Practice Guidelines (2023). Available at: https:\/\/www.escardio.org\/Guidelines\/Clinical-Practice-Guidelines\/Arterial-Hypertension-Management-of. Accessed February 2023."},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101857_bib0010","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamainternmed.2019.7454","article-title":"Comparison of cardiovascular and safety outcomes of chlorthalidone vs hydrochlorothiazide to treat hypertension","volume":"180","author":"Hripcsak","year":"2020","journal-title":"JAMA Int Med"},{"issue":"26","key":"10.1016\/j.cpcardiol.2023.101857_bib0011","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1056\/NEJMoa2212270","article-title":"Chlorthalidone vs. hydrochlorothiazide for hypertension-cardiovascular events","volume":"387","author":"Ishani","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101857_bib0012","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/ajh\/hpac048","article-title":"Thiazide and the thiazide-like diuretics: review of hydrochlorothiazide, chlorthalidone, and indapamide","volume":"35","author":"Ernst","year":"2022","journal-title":"Am J Hypertens"},{"issue":"10","key":"10.1016\/j.cpcardiol.2023.101857_bib0013","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/jch.13386","article-title":"Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing\/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: a systematic review and meta-analysis","volume":"20","author":"Roush","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cpcardiol.2023.101857_bib0014","article-title":"Spironolactone","volume":"2022","author":"Patibandla","year":"2022","journal-title":"StatPearls"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101857_bib0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/ndt\/gfab328","article-title":"Spironolactone and chlorthalidone-old drugs, new uses-but approach with caution","volume":"37","author":"Agarwal","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"18","key":"10.1016\/j.cpcardiol.2023.101857_bib0016","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/jama.2022.19590","article-title":"Treatment of hypertension: a review","volume":"328","author":"Carey","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101857_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-051907","article-title":"Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial","volume":"12","author":"Baptiste","year":"2022","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.cpcardiol.2023.101857_bib0018","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.mayocp.2022.08.009","article-title":"Making a case for the anti-inflammatory effects of ACE inhibitors and angiotensin II receptor blockers: evidence from randomized controlled trials","volume":"97","author":"Issa","year":"2022","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cpcardiol.2023.101857_bib0019","article-title":"Calcium channel blockers","volume":"2022","author":"McKeever","year":"2022"},{"issue":"7","key":"10.1016\/j.cpcardiol.2023.101857_bib0020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ajh\/hpac030","article-title":"Beta-blockers for treatment of hypertension: where do they fit?","volume":"35","author":"Kim","year":"2022","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cpcardiol.2023.101857_bib0021","article-title":"Beta blockers","volume":"2022","author":"Farzam","year":"2022"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101857_bib0022","article-title":"First-line drugs for hypertension","volume":"4","author":"Wright","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101857_bib0023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00129784-200202020-00002","article-title":"Antihypertensive drugs: an overview","volume":"2","author":"Ram","year":"2002","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101857_bib0024","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1097\/MJT.0000000000000224","article-title":"Approach to antihypertensive therapy","volume":"23","author":"Reddy","year":"2016","journal-title":"Am J Ther"},{"issue":"3","key":"10.1016\/j.cpcardiol.2023.101857_bib0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/080370599439715","article-title":"Study on COgnition and Prognosis in the Elderly (SCOPE)","volume":"8","author":"Hansson","year":"1999","journal-title":"Blood Press."},{"issue":"5","key":"10.1016\/j.cpcardiol.2023.101857_bib0026","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jash.2014.02.004","article-title":"Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials","volume":"8","author":"Wang","year":"2014","journal-title":"J Am Soc Hypertens"},{"issue":"4","key":"10.1016\/j.cpcardiol.2023.101857_bib0027","article-title":"Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension","volume":"2008","author":"Heran","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.cpcardiol.2023.101857_bib0028","article-title":"Beta-blockers for hypertension","volume":"1","author":"Wiysonge","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.cpcardiol.2023.101857_bib0029","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1080\/03007995.2017.1341404","article-title":"The cognitive decline in older patients with end stage renal disease (COPE) study: rationale and design","volume":"33","author":"Berkhout-Byrne","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.cpcardiol.2023.101857_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1517\/14656566.6.2.275","article-title":"The avoiding cardiovascular events through COMbination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapies","volume":"6","author":"Weder","year":"2005","journal-title":"Expert Opin Pharmacother"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623002748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623002748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T21:22:09Z","timestamp":1741814529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280623002748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0146280623002748"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101857","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Great Sustainability Results From Appropriate Antihypertensive Therapy","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101857"}}